BFLY Butterfly Network, Inc.
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.…
Industry Peers
Medical DevicesKey Statistics
About Butterfly Network (NYSE: BFLY)
›
Butterfly Network (NYSE: BFLY) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 220 employees.
The shares were at 5.400 USD on 20 November 2026, up 174.1% over 52 weeks. Its 52-week range is 1.900 USD to 10.21 USD: the price is 47.1% below the high and 184.2% above the low.
Its market capitalisation is 1.44B USD.
Butterfly Network reports return on equity of -39.3%, an operating margin of -36.1% and revenue up 51.7% year over year.
It holds more cash than debt, a net cash position of 103.89M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 6 analysts cover the stock; their mean price target of 11.17 USD is 106.8% above the current price. The next earnings report is expected on 25 February 2027.